Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
Conditions: nk/T-cell Lymphoma; Newly Diagnosed; Advanced Lymphoma Intervention: Drug: XPO1 inhibitor Sponsor: Chinese PLA General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials